ID

44416

Description

Safety Study of BAY73-4506 in Patients With Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01003015

Link

https://clinicaltrials.gov/show/NCT01003015

Keywords

Versions (2)
  1. 11/12/17 11/12/17 -
  2. 9/20/21 9/20/21 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

September 20, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Carcinoma, Hepatocellular NCT01003015

English

Eligibility Carcinoma, Hepatocellular NCT01003015

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female patients aged equal or above 18 years.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
bclc stage category a, b or c that cannot benefit from treatments of established efficacy with higher priority such as resection, liver transplantation, local ablation, chemoembolization or systemic sorafenib.
Description

Hepatocellular Carcinoma by BCLC Stage | Therapeutic procedure Established failed | Excision | Transplantation of liver | Local Ablation Therapy | Chemoembolization | Sorafenib Systemic

Data type

boolean

Alias
UMLS CUI [1]
C3898888
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0443211
UMLS CUI [2,3]
C0231175
UMLS CUI [3]
C0728940
UMLS CUI [4]
C0023911
UMLS CUI [5]
C0547070
UMLS CUI [6]
C0796679
UMLS CUI [7,1]
C1516119
UMLS CUI [7,2]
C0205373
liver function status child-pugh class a.
Description

Liver function Child-Pugh Classification

Data type

boolean

Alias
UMLS CUI [1,1]
C0232741
UMLS CUI [1,2]
C4050412
failure to prior treatment with sorafenib (defined as radiological progression under sorafenib therapy)
Description

Sorafenib Therapeutic procedure failed | Disease Progression Radiology

Data type

boolean

Alias
UMLS CUI [1,1]
C1516119
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0231175
UMLS CUI [2,1]
C0242656
UMLS CUI [2,2]
C0043299
local or loco-regional therapy (eg, surgery, radiation therapy, hepatic arterial embolization, chemoembolization, radiofrequency ablation, percutaneous ethanol injection, or cryoablation) must have been completed = 4 weeks before first dose of bay73-4506.
Description

Local Therapy Completed | Therapeutic procedure Local-Regional Completed | Operative Surgical Procedures | Therapeutic radiology procedure | Arterial embolization Hepatic | Chemoembolization | Radiofrequency ablation | Percutaneous ethanol injection therapy | Cryoablation | BAY 73-4506

Data type

boolean

Alias
UMLS CUI [1,1]
C1517925
UMLS CUI [1,2]
C0205197
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C1947913
UMLS CUI [2,3]
C0205197
UMLS CUI [3]
C0543467
UMLS CUI [4]
C1522449
UMLS CUI [5,1]
C3163695
UMLS CUI [5,2]
C0205054
UMLS CUI [6]
C0796679
UMLS CUI [7]
C0850292
UMLS CUI [8]
C1535909
UMLS CUI [9]
C0010408
UMLS CUI [10]
C2703114
ecog ps of 0 or 1.
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
adequate bone marrow, liver and renal function
Description

Bone Marrow function | Liver function | Renal function

Data type

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior systemic treatment with molecular targeted agents for hcc, except sorafenib. prior chemotherapy treatment is allowed.
Description

Systemic therapy | Molecular Targeted Therapy Liver carcinoma | Exception Sorafenib | Prior Chemotherapy allowed

Data type

boolean

Alias
UMLS CUI [1]
C1515119
UMLS CUI [2,1]
C2699893
UMLS CUI [2,2]
C2239176
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C1516119
UMLS CUI [4,1]
C1514457
UMLS CUI [4,2]
C0683607
known history or symptomatic metastatic brain or meningeal tumors (head ct or mri at screening to confirm the absence of central nervous system [cns] disease if patient has symptoms suggestive or consistent with cns disease).
Description

Metastatic malignant neoplasm to brain | Metastatic malignant neoplasm to brain Symptomatic | Meningeal Carcinomatosis | Meningeal Carcinomatosis Symptomatic | CNS disorder Absent CT head | CNS disorder Absent MRI of head | Symptoms Suggestive of CNS disorder | Symptoms Consistent with CNS disorder

Data type

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2,1]
C0220650
UMLS CUI [2,2]
C0231220
UMLS CUI [3]
C0220654
UMLS CUI [4,1]
C0220654
UMLS CUI [4,2]
C0231220
UMLS CUI [5,1]
C0007682
UMLS CUI [5,2]
C0332197
UMLS CUI [5,3]
C0202691
UMLS CUI [6,1]
C0007682
UMLS CUI [6,2]
C0332197
UMLS CUI [6,3]
C0412674
UMLS CUI [7,1]
C1457887
UMLS CUI [7,2]
C0332299
UMLS CUI [7,3]
C0007682
UMLS CUI [8,1]
C1457887
UMLS CUI [8,2]
C0332290
UMLS CUI [8,3]
C0007682
congestive heart failure nyha>/= class 2
Description

Congestive heart failure New York Heart Association Classification

Data type

boolean

Alias
UMLS CUI [1,1]
C0018802
UMLS CUI [1,2]
C1275491
unstable angina (angina symptoms at rest, new onset angina within the last 3 months) or myocardial infarction (mi) within the past 6 months before start of study medication.
Description

Angina, Unstable | Angina symptom At rest | New onset angina | Myocardial Infarction

Data type

boolean

Alias
UMLS CUI [1]
C0002965
UMLS CUI [2,1]
C0858277
UMLS CUI [2,2]
C0443144
UMLS CUI [3]
C0340289
UMLS CUI [4]
C0027051
cardiac arrhythmias requiring anti-arrhythmic therapy (beta blockers or digoxin are permitted).
Description

Cardiac Arrhythmia Requirement Anti-Arrhythmia Agents | Adrenergic beta-1 Receptor Antagonists allowed | Digoxin allowed

Data type

boolean

Alias
UMLS CUI [1,1]
C0003811
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0003195
UMLS CUI [2,1]
C0304516
UMLS CUI [2,2]
C0683607
UMLS CUI [3,1]
C0012265
UMLS CUI [3,2]
C0683607
uncontrolled hypertension (systolic blood pressure > 150 mmhg or diastolic pressure > 90 mmhg despite optimal medical management).
Description

Uncontrolled hypertension | Systolic Pressure | Diastolic blood pressure | Disease Management Optimal

Data type

boolean

Alias
UMLS CUI [1]
C1868885
UMLS CUI [2]
C0871470
UMLS CUI [3]
C0428883
UMLS CUI [4,1]
C0376636
UMLS CUI [4,2]
C2698651
arterial or venous thrombotic or embolic events such as cerebrovascular accident (including transient ischemic attacks), deep vein thrombosis or pulmonary embolism within 6 months before the start of study treatment.
Description

Thrombotic episodes Arterial | Thrombotic episodes Venous | Embolism Arterial | Embolism Venous | Cerebrovascular accident | Transient Ischemic Attack | Deep Vein Thrombosis | Pulmonary Embolism

Data type

boolean

Alias
UMLS CUI [1,1]
C2674163
UMLS CUI [1,2]
C0221464
UMLS CUI [2,1]
C2674163
UMLS CUI [2,2]
C0348013
UMLS CUI [3,1]
C0013922
UMLS CUI [3,2]
C0221464
UMLS CUI [4,1]
C0013922
UMLS CUI [4,2]
C0348013
UMLS CUI [5]
C0038454
UMLS CUI [6]
C0007787
UMLS CUI [7]
C0149871
UMLS CUI [8]
C0034065
Back to the top of the page

Similar models

Eligibility Carcinoma, Hepatocellular NCT01003015

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
male or female patients aged equal or above 18 years.
boolean
C0001779 (UMLS CUI [1])
Hepatocellular Carcinoma by BCLC Stage | Therapeutic procedure Established failed | Excision | Transplantation of liver | Local Ablation Therapy | Chemoembolization | Sorafenib Systemic
Item
bclc stage category a, b or c that cannot benefit from treatments of established efficacy with higher priority such as resection, liver transplantation, local ablation, chemoembolization or systemic sorafenib.
boolean
C3898888 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0443211 (UMLS CUI [2,2])
C0231175 (UMLS CUI [2,3])
C0728940 (UMLS CUI [3])
C0023911 (UMLS CUI [4])
C0547070 (UMLS CUI [5])
C0796679 (UMLS CUI [6])
C1516119 (UMLS CUI [7,1])
C0205373 (UMLS CUI [7,2])
Liver function Child-Pugh Classification
Item
liver function status child-pugh class a.
boolean
C0232741 (UMLS CUI [1,1])
C4050412 (UMLS CUI [1,2])
Sorafenib Therapeutic procedure failed | Disease Progression Radiology
Item
failure to prior treatment with sorafenib (defined as radiological progression under sorafenib therapy)
boolean
C1516119 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C0242656 (UMLS CUI [2,1])
C0043299 (UMLS CUI [2,2])
Local Therapy Completed | Therapeutic procedure Local-Regional Completed | Operative Surgical Procedures | Therapeutic radiology procedure | Arterial embolization Hepatic | Chemoembolization | Radiofrequency ablation | Percutaneous ethanol injection therapy | Cryoablation | BAY 73-4506
Item
local or loco-regional therapy (eg, surgery, radiation therapy, hepatic arterial embolization, chemoembolization, radiofrequency ablation, percutaneous ethanol injection, or cryoablation) must have been completed = 4 weeks before first dose of bay73-4506.
boolean
C1517925 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C1947913 (UMLS CUI [2,2])
C0205197 (UMLS CUI [2,3])
C0543467 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
C3163695 (UMLS CUI [5,1])
C0205054 (UMLS CUI [5,2])
C0796679 (UMLS CUI [6])
C0850292 (UMLS CUI [7])
C1535909 (UMLS CUI [8])
C0010408 (UMLS CUI [9])
C2703114 (UMLS CUI [10])
ECOG performance status
Item
ecog ps of 0 or 1.
boolean
C1520224 (UMLS CUI [1])
Bone Marrow function | Liver function | Renal function
Item
adequate bone marrow, liver and renal function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Systemic therapy | Molecular Targeted Therapy Liver carcinoma | Exception Sorafenib | Prior Chemotherapy allowed
Item
prior systemic treatment with molecular targeted agents for hcc, except sorafenib. prior chemotherapy treatment is allowed.
boolean
C1515119 (UMLS CUI [1])
C2699893 (UMLS CUI [2,1])
C2239176 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C1516119 (UMLS CUI [3,2])
C1514457 (UMLS CUI [4,1])
C0683607 (UMLS CUI [4,2])
Metastatic malignant neoplasm to brain | Metastatic malignant neoplasm to brain Symptomatic | Meningeal Carcinomatosis | Meningeal Carcinomatosis Symptomatic | CNS disorder Absent CT head | CNS disorder Absent MRI of head | Symptoms Suggestive of CNS disorder | Symptoms Consistent with CNS disorder
Item
known history or symptomatic metastatic brain or meningeal tumors (head ct or mri at screening to confirm the absence of central nervous system [cns] disease if patient has symptoms suggestive or consistent with cns disease).
boolean
C0220650 (UMLS CUI [1])
C0220650 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
C0220654 (UMLS CUI [3])
C0220654 (UMLS CUI [4,1])
C0231220 (UMLS CUI [4,2])
C0007682 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
C0202691 (UMLS CUI [5,3])
C0007682 (UMLS CUI [6,1])
C0332197 (UMLS CUI [6,2])
C0412674 (UMLS CUI [6,3])
C1457887 (UMLS CUI [7,1])
C0332299 (UMLS CUI [7,2])
C0007682 (UMLS CUI [7,3])
C1457887 (UMLS CUI [8,1])
C0332290 (UMLS CUI [8,2])
C0007682 (UMLS CUI [8,3])
Congestive heart failure New York Heart Association Classification
Item
congestive heart failure nyha>/= class 2
boolean
C0018802 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Angina, Unstable | Angina symptom At rest | New onset angina | Myocardial Infarction
Item
unstable angina (angina symptoms at rest, new onset angina within the last 3 months) or myocardial infarction (mi) within the past 6 months before start of study medication.
boolean
C0002965 (UMLS CUI [1])
C0858277 (UMLS CUI [2,1])
C0443144 (UMLS CUI [2,2])
C0340289 (UMLS CUI [3])
C0027051 (UMLS CUI [4])
Cardiac Arrhythmia Requirement Anti-Arrhythmia Agents | Adrenergic beta-1 Receptor Antagonists allowed | Digoxin allowed
Item
cardiac arrhythmias requiring anti-arrhythmic therapy (beta blockers or digoxin are permitted).
boolean
C0003811 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0003195 (UMLS CUI [1,3])
C0304516 (UMLS CUI [2,1])
C0683607 (UMLS CUI [2,2])
C0012265 (UMLS CUI [3,1])
C0683607 (UMLS CUI [3,2])
Uncontrolled hypertension | Systolic Pressure | Diastolic blood pressure | Disease Management Optimal
Item
uncontrolled hypertension (systolic blood pressure > 150 mmhg or diastolic pressure > 90 mmhg despite optimal medical management).
boolean
C1868885 (UMLS CUI [1])
C0871470 (UMLS CUI [2])
C0428883 (UMLS CUI [3])
C0376636 (UMLS CUI [4,1])
C2698651 (UMLS CUI [4,2])
Thrombotic episodes Arterial | Thrombotic episodes Venous | Embolism Arterial | Embolism Venous | Cerebrovascular accident | Transient Ischemic Attack | Deep Vein Thrombosis | Pulmonary Embolism
Item
arterial or venous thrombotic or embolic events such as cerebrovascular accident (including transient ischemic attacks), deep vein thrombosis or pulmonary embolism within 6 months before the start of study treatment.
boolean
C2674163 (UMLS CUI [1,1])
C0221464 (UMLS CUI [1,2])
C2674163 (UMLS CUI [2,1])
C0348013 (UMLS CUI [2,2])
C0013922 (UMLS CUI [3,1])
C0221464 (UMLS CUI [3,2])
C0013922 (UMLS CUI [4,1])
C0348013 (UMLS CUI [4,2])
C0038454 (UMLS CUI [5])
C0007787 (UMLS CUI [6])
C0149871 (UMLS CUI [7])
C0034065 (UMLS CUI [8])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial